Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis

Clinical trial NCT01077531 · TERMINATED

Trial details

NCT number: NCT01077531
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2010-04-28
Primary completion: 2013-03-19
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.